[HTML][HTML] Tweaking progranulin expression: therapeutic avenues and opportunities

J Terryn, CM Verfaillie, P Van Damme - Frontiers in Molecular …, 2021 - frontiersin.org
Frontotemporal dementia (FTD) is a neurodegenerative disease, leading to behavioral
changes and language difficulties. Heterozygous loss-of-function mutations in progranulin …

[HTML][HTML] Microglial progranulin: involvement in Alzheimer's disease and neurodegenerative diseases

A Mendsaikhan, I Tooyama, DG Walker - Cells, 2019 - mdpi.com
Neurodegenerative diseases such as Alzheimer's disease have proven resistant to new
treatments. The complexity of neurodegenerative disease mechanisms can be highlighted …

[HTML][HTML] Preclinical interventions in mouse models of frontotemporal dementia due to progranulin mutations

SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - Elsevier
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …

Progranulinopathy: A diverse realm of disorders linked to Progranulin imbalances

G Huang, J Jian, CJ Liu - Cytokine & Growth Factor Reviews, 2023 - Elsevier
Progranulin (PGRN), encoded by the GRN gene in humans, was originally isolated as a
secreted growth factor that implicates in a multitude of processes ranging from regulation of …

[HTML][HTML] Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: Increased levels correlate …

A Mendsaikhan, I Tooyama, JP Bellier… - Acta Neuropathologica …, 2019 - Springer
Progranulin (PGRN) is a protein encoded by the GRN gene with multiple identified functions
including as a neurotrophic factor, tumorigenic growth factor, anti-inflammatory cytokine and …

[HTML][HTML] Pathological hemodynamic changes and leukocyte transmigration disrupt the blood–spinal cord barrier after spinal cord injury

R Zhou, J Li, Z Chen, R Wang, Y Shen, R Zhang… - Journal of …, 2023 - Springer
Background Blood–spinal cord barrier (BSCB) disruption is a key event after spinal cord
injury (SCI), which permits unfavorable blood-derived substances to enter the neural tissue …

[HTML][HTML] Neuroimmune dysfunction in frontotemporal dementia: insights from progranulin and C9orf72 deficiency

K Hashimoto, N Jahan, ZA Miller, EJ Huang - Current opinion in …, 2022 - Elsevier
Neuroimmune dysfunction is a cardinal feature of neurodegenerative diseases. But how
immune dysregulation in the brain and peripheral organs contribute to neurodegeneration …

[PDF][PDF] Harnessing immunoproteostasis to treat neurodegenerative disorders

TE Golde - Neuron, 2019 - cell.com
Immunoproteostasis is a term used to reflect interactions between the immune system and
the proteinopathies that are presumptive" triggers" of many neurodegenerative disorders …

[HTML][HTML] Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway

T Dong, L Tejwani, Y Jung, H Kokubu, K Luttik… - JCI insight, 2021 - ncbi.nlm.nih.gov
Genetic variants in Granulin (GRN), which encodes the secreted glycoprotein progranulin
(PGRN), are associated with several neurodegenerative diseases, including frontotemporal …

[HTML][HTML] Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease

DA Gillett, RL Wallings, O Uriarte Huarte… - Journal of …, 2023 - Springer
Background Alterations in progranulin (PGRN) expression are associated with multiple
neurodegenerative diseases (NDs), including frontotemporal dementia (FTD), Alzheimer's …